SCHEMBL6710409

SCHEMBL6710409

Cn1c(C(=O)Nc2ccc(Br)cc2-c2noc(=O)[nH]2)cc2c(Br)ccc(NC(=O)Cc3ccccc3)c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.36
GAA P10253 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
HIF1A Q16665 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA5A P35218 1/20 0.34
CA7 P43166 1/20 0.34
CA5B Q9Y2D0 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
ADORA2B P29275 1/20 0.34
BRPF1 P55201 2/20 0.33
LMNA P02545 1/20 0.33
PARP14 Q460N5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710187 0.92 F11 (0.40) GRIK1GAAKDM4EALDH1A1KMT2A
SCHEMBL6711947 0.91 GRIK1 (0.35) GRIK1GAAKDM4EALDH1A1KMT2A
SCHEMBL6709930 0.90 PARP14 (0.37) GAAKDM4EALDH1A1CA1CA2
SCHEMBL6713282 0.84 HIF1A (0.40) GAAKDM4EALDH1A1KMT2AMEN1
SCHEMBL6708833 0.84 GRIK1 (0.38) GRIK1KDM4EKMT2AMEN1HIF1A
SCHEMBL6709860 0.84 GRIK1 (0.39) GRIK1GAAKDM4EALDH1A1KMT2A
SCHEMBL6709195 0.83 CASP3 (0.36) GRIK1GAAKDM4EALDH1A1KMT2A
SCHEMBL6708003 0.82 KMT2A (0.32) GRIK1GAAKDM4EALDH1A1KMT2A
SCHEMBL6710244 0.82 PARP14 (0.34) GRIK1GAAKDM4EALDH1A1TP53
SCHEMBL6710260 0.81 GRIK1 (0.38) GRIK1KDM4EKMT2AMEN1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885GAA 111/4885KDM4E 1582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.